Press Releases genOway

Equities

ALGEN

FR0004053510

Market Closed - Euronext Paris Other stock markets 11:19:19 2024-05-02 am EDT			5-day change	1st Jan Change
4.16 ^EUR	+0.24%		+5.58%	-9.57%

2023	GenOway: sharp rise, broker initiates buy recommendation	CF
2023	GENOWAY : Euroland initiates buy coverage	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GenOway : Résultats annuels 2023	Mar. 27	PU
GenOway : Résultats du 1er semestre 2023	23-09-22	PU
GenOway: Proposal of a new administrator	22-05-23	PU
GenOway grants the leading UK academic research funder a non-exclusive license for CRISPR/Cas9 technology	22-01-25	PR
GenOway : and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models	20-01-07	AQ
GenOway : The Institut Pasteur and Cellectis extend exclusive license rights by granting genOway the authority to take action against infringement	19-11-04	PU
Genoway : Conventional KO (constitutive)	16-07-26	PU
GENOWAY : A grant for €1.9 million has been awarded under the Eurostars™ programme to a consortium that comprises Abzena, Antitope, Prothix BV, Aristi Biotech BV, the University Medical Center Utrecht, and genOway	16-01-28	PU
GENOWAY : The 11th ISTT Prize will be jointly awarded to Jennifer Doudna and Emmanuelle Charpentier at the TT2016 meeting.	15-04-23	PU
GENOWAY : Genetically Modified Models by CRISPR/Cas9 Nuclease System	14-09-08	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer